Physician profile
Bronte E Naples
NPI 1992291926
$26,362.20
in general payments reported to CMS, 2019-2025
16 companies · $9,886 in 2025
The $9,886 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,306 · 2022: $1,097 · 2023: $5,140 · 2024: $8,935 · 2025: $9,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $3,259 · Food and Beverage: $2,956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,745.00 |
| Travel and Lodging | $3,259.20 |
| Food and Beverage | $2,955.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $23,958.50 | 2021-2025 | Biktarvy, Yeztugo, Epclusa |
| Abbvie INC. | $684.92 | 2021-2023 | |
| Viiv Healthcare Company | $304.51 | 2021-2025 | Dovato, Cabenuva |
| Novo Nordisk INC | $288.36 | 2021-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals Lp | $280.56 | 2021-2023 | Fasenra |
| Janssen Products, Lp | $251.97 | 2021-2022 | |
| Boston Scientific Corporation | $131.42 | 2023 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $124.17 | 2021-2022 | |
| Mylan Specialty L.P. | $123.51 | 2022 | |
| Janssen Biotech, INC. | $69.32 | 2021-2022 | |
| Coopersurgical, INC. | $41.75 | 2022 | |
| Theratechnologies INC. | $32.93 | 2021-2023 | Trogarzo, Egrifta |
| Pfizer INC. | $23.37 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $22.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.30 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bronte Naples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.